Program by Topic
Y-90 Peripheral vascular disease
Sessions on Y-90 and peripheral vascular disease will be held Friday, October 18 and Saturday, October 19. See schedule-at-a-glance for times.
** All sessions and special events are held at the Grand Hyatt Denver Hotel on the 38th floor.
Y-90
Track Coordinators: Robert J. Lewandowski, MD, FSIR, Nora Tabori, MD, Siddharth A. Padia, MD, FSIR, Nima Kokabi, MD
The radioembolization-intensive course provides learners the opportunity to advance their radioembolization practices through a combination of didactics, debates, interactive hand-on workshops. Topics will include patient selection for both primary and secondary liver cancer, when and why to use personalized dosimetry models, and how to implement dosimetry software in your practice. This course provides a framework for building and maintaining a radioembolization program in all practice settings and at all career stages. The learner can expect to be brought up to speed on current best practice and learn about developing concepts for this exciting therapy.
What will you learn?
1. Evidence-based angiographic and dosimetric techniques: the science of how to optimize your patient's outcome.
2. Dosimetry software: the when and the why.
3. Building and maintaining a radioembolization program: how to navigate and stay relevant in this multidisciplinary world
Friday, Oct. 18
How to do a Y-90
10:45 a.m. -12 p.m.
Moderator: Siddharth A. Padia, MD, FSIR
- 10:45-10:55 a.m. Who is High-Risk for TARE?- Nora Tabori, MD
- 10:55-11:05 a.m. Managing Systemic Therapies peri-TARE- Ammar Sarwar, MD, FSIR
- 11: 05-11:15 a.m. M&M: Hepatic Angiography Edition- Robert J. Lewandowski, MD, FSIR
- 11:15-11:25 a.m.- First Do No Harm: Parenchymal Sparing Techniques- Beau Toskich MD, FSIR
- 11:25-11:35 a.m.- CBCT: Up Your Game- Siddharth A. Padia, MD, FSIR
- 11:35-11: 45 a.m.- Complexities of Post-Y-90 Imaging- Marnix Lam, MD
- 11:45 a.m. -12 p.m.- Panel Discussion- Nora Tabori, MD, Ammar Sarwar, MD, FSIR, Robert J. Lewandowski, MD, FSIR, Beau Toskich MD, FSIR, Siddharth A. Padia, MD, FSIR, Marnix Lam, MD
Opening Day Debates
Moderator: Robert J. Lewandowski, MD, FSIR
1-2:45 p.m.
- 1-1:20 p.m.- Do We Need a Better Surrogate than MAA? with Nima Kokabi, MD and Dan Brown, MD, FSIR
- 1:20-1:40 p.m.- Let’s Get Technical: Free-flow vs. Pressure-driven Embolization for Y-90 with Kirema Garcia-Reyes, MD vs. Guy Johnson, MD
- 1:40- 2 p.m.- Personalized Dosimetry is the Wave of the Future, or Not… with Shamar Young, MD and Nora Tabori, MD
- 2- 2:20 p.m.- Is There a Better Isotope than Y-90? with Marnix Lam, MD vs. Beau Toskich MD, FSIR
- 2:20-2:40 p.m.- Post Y-90 imaging: Necessary or Waste of Time? with Ammar Sarwar, MD vs. Dan Brown, MD,FSIR
- 2:40-2:45 p.m. -Panel Discussion- Nima Kokabi, MD and Dan Brown, MD, FSIR, Kirema Garcia-Reyes, MD vs. Guy Johnson, MD, Shamar Young, MD and Nora Tabori, MD, Marnix Lam, MD vs. Beau Toskich MD, FSIR, Ammar Sarwar, MD vs. Edward Kim, MD,FSIR
Saturday, Oct. 19
Hepatocellular Carcinoma
Moderator: Edward Kim, MD,FSIR
8-11 a.m.
- 8- 8:15 a.m.- Y-90 vs. SBRT- Beau Toskich, MD, FSIR
- 8:15-8:30 a.m.- Y-90 via Extra-hepatic Branches- Edward Kim, MD,FSIR
- 8:30-8:55 a.m.- Early HCC:Radioembolization as Curative Intent- Robert J. Lewandowski, MD, FSIR
- 8:55-9:20 a.m.- Intermediate HCC: Does Emerald 1 Change how We Practice?- Riad Salem, MD, MBA, FSIR
- 9:20- 9:45 a.m.- Advanced HCC: What Should the Next Iteration of BCLC Look Like?-Nora Tabori, MD
- 9:45- 10 a.m.- Y-90 + IO—Is There a Synergistic Signal?- Guy Johnson, MD
- 10-10:15 a.m.- Summary: Studies to Know for Tumor Board- Siddharth A. Padia, MD, FSIR
- 10:15-10:30 a.m.- Cholangiocarcinoma: Is it all About Getting pts to Resection?- Ammar Sarwar, MD, FSIR
- 10:30-11 a.m. Panel/Case Discussion- Beau Toskich, MD, FSIR, Edward Kim, MD,FSIR, Robert J. Lewandowski, MD, FSIR, Riad Salem, MD, MBA, FSIR, Nora Tabori, MD, Guy Johnson, MD, Siddharth A. Padia, MD, FSIR, Ammar Sarwar, MD, FSIR
Seconday Hepatic Malignancies
Moderator: Nima Kokabi, MD
1-2:15 p.m.
- 1-1:10 p.m.- mCRC: Is This the End of the Line for Y-90?- Nima Kokabi, MD
- 1:10-1:20 p.m.- mNET: PRRT Versus TARE vs. TAE—Which and When- Marnix Lam, MD
- 1:20-1:30 p.m.- RAD SEG for Oligometastatic Disease—Path Forward- Kirema Garcia-Reyes, MD
- 1:30-1:50 p.m.- Debate: Downstaging to Resection/OLT: Y-90 vs. PVE with Robert J. Lewandowski, MD, FSIR and Edward Kim, MD,FSIR
- 1:50- 2:10 p.m.- Debate: Uveal Melanoma: Y-90 vs. Hepzato with Daniel B. Brown, MD, FSIR and Siddharth A. Padia, MD, FSIR
- 2:10-2:15 p.m. Panel Discussion- Nima Kokabi, MD, Marnix Lam, MD,Kirema Garcia-Reyes, MD, Robert J. Lewandowski, MD, FSIR, Edward Kim, MD,FSIR, Daniel B. Brown, MD, FSIR, Siddharth A. Padia, MD, FSIR
Finishing Touches
Moderator: Nora Tabori, MD
2:30-4 p.m.
- 2:30-2:40 p.m.- Quality Metrics to Know- Siddharth A. Padia, MD, FSIR
- 2:40-2:50 p.m.- Y-90: Is Cost Still an Issue?- Edward Kim, MD,FSIR
- 2:50-3 p.m.- Coding and Billing in the Dosimetry Space- Kirema Garcia-Reyes, MD
- 3-3:10 p.m.- Y-90 in the OBL - Nora Tabori, MD
- 3:10-3:20 p.m.- Y-90 Outside the Liver- Riad Salem, MD, MBA, FSIR
- 3:20-3:30 p.m.- Next Generation Devices: What do we Really Want?- Marnix Lam, MD
- 3:30-4 p.m. Panel Discussion- Siddharth A. Padia, MD, FSIR, Edward Kim, MD,FSIR, Kirema Garcia-Reyes, MD, Nora Tabori, MD, Riad Salem, MD, MBA, FSIR, Marnix Lam, MD
Peripheral Vascular Disease
Track Coordinators: Luke Wilkins, MD, FSIR, Bulent Arslan, MD, FSIR, Mary Costantino, MD, FSIR, Timothy Clark, MD, FSIR
This program is designed for the practicing interventional radiologist seeking to expand their peripheral vascular disease skills and enable treatment of a broader spectrum of patients, including chronic critical limb-threatening ischemia and patients who have failed prior attempts at endovascular therapy. Attendees will also learn best practices for endovascular therapy of deep venous thrombosis and post thrombotic syndrome.
What will you learn?
- How to incorporate best practices and latest endovascular techniques into a peripheral vascular disease program including patient assessment, workup and optimal limb salvage therapy.
- How to avoid and manage endovascular complications in the care of peripheral vascular disease patients.
- How to perform thrombectomy/thrombolysis of acute deep venous thrombosis and manage post thrombotic syndrome.
- Understand emerging and future endovascular technologies for peripheral vascular disease.
Session topics include:
Friday, Oct. 18
Peripheral Arterial Disease: A Day in the IR Vascular Clinic
Moderator: Luke Wilkins, MD, FSIR
10:45 a.m.- 12 p.m.
- 10:45- 11 a.m.- New AHA PAD Guidelines and GDMT: How Will they Change What you Do- Luke Wilkins, MD, FSIR
- 11- 11:10 a.m.- Pre-procedure Imaging: Who, What and Why? with J. Fritz Angle, MD, FSIR vs. Kumar Madassery, MD, FSIR
- 11:10-11:20 a.m.- Panel Discussion
- 11:20- 11:40 a.m.- When is Endovascular Therapy of Claudication Appropriate?- Rahul Patel, MD, FSIR
- 11:40-11:50 a.m.- Developing a Successful Limb Salvage Program and Wound Clinic- Kumar Madassery, MD, FSIR
- 11:50 a.m.- 12 p.m.- Deciphering BEST-CLI and BASIL 2 for your Limb Salvage Team- Brian J. Schiro, MD, RPVI, FSIR
Peripheral Arterial Disease: Limb Salvage from the Straightforward to the Extreme
Moderator: Timothy Clark, MD, FSIR
1-2:45 p.m.
- 1-1:10 p.m.- CERAB for Aortoiliac Disease: The Complex Made Simple- Bulent Arslan, MD, FSIR
- 1:10-1:20 p.m.- Isolated Iliac Occlusion: How to Treat Without Compromising the Aorta or Contralateral Iliac- J. Fritz Angle, MD, FSIR
- 1:20-1:25 p.m. Panel Discussion
- 1:25- 1:35 p.m.- CFA Endovascular Intervention—Cases- Timothy Clark, MD, FSIR
- 1:35-1:45 p.m.- Essential Techniques for Crossing Femoropopliteal Chronic Total Occlusions- Luke Wilkins, MD, FSIR
- 1:45- 1:55 p.m.- Tibial Chronic Total Occlusions—Tips for Successful Recanalization- Timothy Clark, MD, FSIR
- 1:55-2 p.m.- Panel Discussion
- 2-2:10 p.m.- Atherectomy Devices—Judicial Use of the Most Controversial Device on the Planet-Rahul Patel, MD, FSIR
- 2:10-2:20 p.m.- The Pedal Loop: When and How- Ansar Z. Vance, MD
- 2:20-2:30 p.m- Managing Post PVI Thrombosis: Thrombectomy Strategies- Brian J. Schiro, MD, RPVI, FSIR
- 2:30-2:40 p.m.-When and How to do Deep Venous Arterialization- Kumar Madassery, MD, FSIR
- 2:40-2:45 p.m.- Panel Discussion
Saturday, Oct. 19
Peripheral arterial disease: Avoiding and managing complications
Moderator: Luke Wilkins, MD, FSIR
8:30- 10 a.m.
- 8:30- 8:40 p.m.- When IVUS Helps Avoid Device Sizing Complications- Mary Costantino, MD, FSIR
- 8:40- 8:50 p.m.- Advances in Thrombus Management in Acute Limb Ischemia- Rahul Patel, MD, FSIR
- 8:50- 9 a.m.- Preventing and Managing Distal Emboli- Bulent Arslan, MD, FSIR
- 9- 9:10 a.m.- Optimizing Stent Selection for Femoropopliteal Arteries to Avoid Strut Fractures and Occlusions- Ansar Z. Vance, MD
- 9:10-9:20 a.m.- Panel Discussion
- 9:20-9:30 a.m.- The Venous Storm Post DVA: Managing DVA Complications- Kumar Madassery, MD, FSIR
- 9:30-9:50 a.m.- Managing the Rare but Potentially Devastating Tibial Perforation- Brian J. Schiro, MD, RPVI, FSIR
- 9:50-10 a.m.- Avoiding and Managing Iliac Perforation- Luke Wilkins, MD, FSIR
Deep Venous Dive 1: DVT Thrombectomy/Thrombolysis
Moderator: Timothy Clark, MD, FSIR
10-11 a.m.
- 10-10: 20 a.m.- DVT Thrombolysis: Lytics Can Be Given More Effectively than Ever- Akhilesh K. Sista, MD, FSIR
- 10:20-10:40 a.m.- DVT Thrombectomy: Single Session Mechanical Thrombectomy Without Lytics is Here to Stay- Timothy Clark, MD, FSIR
- 10:40- 11 a.m.- Anticoagulation Approaches Post DVT Thrombectomy/Thrombolysis: What Does the Evidence Say? -J. Fritz Angle, MD, FSIR
Peripheral Arterial Disease: Practice Development
Moderator: Bulent Arslan, MD, FSIR
1-1:40 p.m.
- 1-1:10 p.m.- Working with Other Vascular Specialists- Luke Wilkins, MD, FSIR
- 1:10- 1:20 p.m.- Out on your Own: OBL vs. ASC vs. Hybrid and How to Choose- Mary Costantino, MD, FSIR
- 1:20-1:30 p.m.- OBLs in Academic IR: A Marriage Doomed to Fail or a Flourishing Future- Bulent Arslan, MD, FSIR
- 1:30-1:40 p.m.- Independent IR practice: what to know before you make the leap- Mary Costantino, MD, FSIR
Deep Venous Dive 2: Iliac/Caval Reconstruction in Post Thrombotic Syndrome
Moderator: Timothy Clark, MD, FSIR
1:40-2:15 p.m.
- 1:40-1:50 p.m.- When to and When not to Stent Iliac Veins in Post Thrombotic Syndrome- Elizabeth B. Spencer, MD, FSIR
- 1:50-2 p.m.- Preventing and Managing Iliac Venous Stent Occlusions-Akhilesh K. Sista, MD, FSIR
- 2-2:15 p.m.- Complex Iliac/Caval Reconstruction: Cases- Elizabeth B. Spencer, MD, FSIR
Peripheral Arterial Disease: The Future Is Now
Moderator: Luke Wilkins, MD, FSIR
2:30-4 p.m.
- 2:30- 2:40 p.m.- Bioabsorbable Scaffolds for Below-Knee Disease: Present and Future- Timothy Clark, MD, FSIR
- 2:40-2:50 p.m.- Radial to Peripheral Approach—New Horizon or More Hurdles than you Need with J. Fritz Angle, MD, FSIR vs. Rahul Patel, MD, FSIR
- 2:50-3 p.m.- Next Generation Drug-Eluting Balloon Technologies- Ansar Z. Vance, MD
- 3-3:10 p.m.- Drug Eluting Stents: Technology Differences You Need to Know- Kumar Madassery, MD, FSIR
- 3:10-3:20 p.m.- Off the Beaten Path—Alternative Arterial Access Sites: SFA, Through-stent, Tibial/Pedal- Bulent Arslan, MD, FSIR
- 3:20-3:30 p.m. Intravascular Lithotripsy: Game Changer or Another Tool in the Box?- J. Fritz Angle, MD, FSIR
- 3:30-3:40 p.m.- Detour System for Chronic Femoropopliteal Occlusions- Brian J. Schiro, MD, RPVI, FSIR
- 3:40-3:50 p.m.- What will SFA Stents Look Like in 10 Years?- Kumar Madassery, MD, FSIR
- 3:50-4 p.m.- Panel Discussion- Timothy Clark, MD, FSIR, J. Fritz Angle, MD, FSIR, Rahul Patel, MD, FSIR, Ansar Z. Vance, MD, Kumar Madassery, MD, FSIR, Bulent Arslan, MD, FSIR, Brian J. Schiro, MD, RPVI, FSIR